A team of American scientists has identified an anti-influenza drug that can block the transmission of Covid-19 within 24 hours, according to a study published in the journal Nature Microbiology.
BUCHAREST, December 4 – Sputnik. A new anti-influenza drug, MK-4482 / EIDD-2801, called Molnupiravir, blocks the transmission of SARS-CoV-2 coronavirus, according to a study led by a team of researchers at Georgia State University and Richard Plemper.
According to the results published in the journal Nature Microbiology, Molnupiravir gives good results in the early stages of Covid-19 and has been shown to be effective against other RNA viruses.
Study with ferrets
The scientists conducted research on SARS-CoV-2-infected ferrets, and were given the drug twice a day orally.
“We studied the efficacy of therapeutically administered MK-4482 / EIDD-2801 to improve SARS-CoV-2 infection and block ferret transmission, as ferrets transmit the virus easily but show minimal clinical signs similar to the spread of the virus to a young human population. Adults,” said researchers Sputnik France in the research cited by.
Tests have shown that MK-4482 / EIDD-2801 severely prevented Covid-19 from passing through and could block virus transmission for 24 hours.
Molnupiravir is currently in the 2/3 phase of clinical trials, the researchers say. Scientists expect that if efficacy is confirmed, patients with Covid-19 will stop transmitting SARS-CoV-2 to others within 24 hours of starting treatment.